Characteristics | Training cohort (n = 100) | Validation cohort (n = 48) | p value |
---|---|---|---|
Age, years | Â | Â | 0.055 |
 Median [range] | 58 [20, 76] | 61 [42, 83] |  |
Sex, no. (%) | Â | Â | 0.220 |
 Male | 79/100 (79%) | 33/48 (68.75%) |  |
 Female | 21/100 (21%) | 15/48 (31.25%) | |
Smoking, no. (%) | Â | Â | 0.707 |
 Yes | 70/100 (70%) | 32/48 (66.7%) |  |
 No | 30/100 (30%) | 16/48 (33.3%) |  |
Side, no. (%) | Â | Â | 0.389 |
 Upper left lobe | 34/100 (34%) | 12/48 (25%) |  |
 Lower left lobe | 14/100 (14%) | 8/48 (16.7%) |  |
 Upper right lobe | 22/100 (22%) | 12/48 (25%) |  |
 Middle right lobe | 4/100 (4%) | 2/48 (4.2%) |  |
 Lower right lobe | 26/100 (26%) | 14/48 (29.1%) |  |
Location, no. (%) | Â | Â | 0.216 |
 Peripheral | 63/100 (63%) | 25/48 (52.1%) |  |
 Central | 37/100 (37%) | 23/48 (47.9%) |  |
LD, mma | Â | Â | 0.230 |
 Median [range] | 54 [10, 115] | 43.5 [15, 100] |  |
LPD, mma | Â | Â | 0.838 |
 Median [range] | 36.5 [8, 77] | 35 [11, 90] |  |
CEA, (ng/ml)a | Â | Â | 0.380 |
 Median [range] | 4.7 [0.486, 1135] | 7.11 [1.19, 646.4] |  |
Histological subtype, no. (%) | Â | Â | 0.164 |
 Squamous cell carcinoma | 50/100 (50%) | 18/48 (37.5%) |  |
 Adenocarcinoma | 50/100 (50%) | 30/48 (62.5%) |  |